Trinity Biotech ( TRIB -2.3% ) will report Q3 results on October 23. The conference call will begin at 11:00 am ET. Consensus view is EPS of $0.20 on revenues of $27.3M. Post your comment!
showed Trinity Biotech Plc (NASDAQ: TRIB ), flaunted a 75.09% price upside to lead the healthcare sector. However, the TRIB dog did not even throw enough dividend ..... 3% to 34.53% Upsides; Low Yielder TRIB Was Slated to Hit 75% The charts above
buying AZN ; pg 19]; Tullow Oil [TLW.uk; pg 20]; Irish small-cap medical testing equipment maker Trinity Biotech [ TRIB ; pg 40]. AIG story http://online.barrons.com/news/articles/SB50001424053111903409104579515680983549344?mod
150; pg 20]; global energy producer Hess [ HES ; pg 22]; medical testing equipment/instrument maker Trinity Biotech [ TRIB ; for diabetes at $25,000/device, Lyme disease, autoimmune disorders, herpes, syphilis, strep pneumonia, cardiac evaluation
spinoff from Kraft ( KFT ) whose new ticker will be KRFT ; pg 16); diabetes and other testing equipment maker Trinity Biotech ( TRIB ; pg 19); Steelcase ( SCS ; pg 20; see link below). SCS story http://online.barrons.com/article/SB50001424053111904414004578016383267957450